{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:12:59Z","timestamp":1769116379902,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12020-019-02070-0","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T12:03:02Z","timestamp":1567512182000},"page":"467-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Association between nonalcoholic fatty liver disease and cardiac function and structure\u2014a meta-analysis"],"prefix":"10.1007","volume":"66","author":[{"given":"Marta","family":"Borges-Canha","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Diogo","family":"Lib\u00e2nio","sequence":"additional","affiliation":[]},{"given":"Madalena","family":"Von-Hafe","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Vale","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Ara\u00fajo-Martins","sequence":"additional","affiliation":[]},{"given":"Ana Rita","family":"Leite","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Pimentel-Nunes","sequence":"additional","affiliation":[]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Adelino","family":"Leite-Moreira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"issue":"7","key":"2070_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.17235\/reed.2017.4575\/2016","volume":"109","author":"M Borges Canha","year":"2017","unstructured":"M. Borges Canha, J.P. Portela-Cidade, G. Conceicao, C. Sousa-Mendes, S. Leite, D. Fontoura et al. Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. Rev. Esp. Enferm. Dig. 109(7), 491\u2013497 (2017). \nhttps:\/\/doi.org\/10.17235\/reed.2017.4575\/2016\n\n.","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"1","key":"2070_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Z.M. Younossi, A.B. Koenig, D. Abdelatif, Y. Fazel, L. Henry, M. Wymer, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1), 73\u201384 (2016). \nhttps:\/\/doi.org\/10.1002\/hep.28431\n\n.","journal-title":"Hepatology"},{"issue":"7","key":"2070_CR3","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, K. Cusi et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142(7), 1592\u20131609 (2012). \nhttps:\/\/doi.org\/10.1053\/j.gastro.2012.04.001\n\n.","journal-title":"Gastroenterology"},{"issue":"5","key":"2070_CR4","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"M. Ekstedt, H. Hagstrom, P. Nasr, M. Fredrikson, P. Stal, S. Kechagias et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61(5), 1547\u20131554 (2015). \nhttps:\/\/doi.org\/10.1002\/hep.27368\n\n.","journal-title":"Hepatology"},{"issue":"11","key":"2070_CR5","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.dld.2018.09.004","volume":"50","author":"K Wijarnpreecha","year":"2018","unstructured":"K. Wijarnpreecha, S. Lou, P. Panjawatanan, W. Cheungpasitporn, S. Pungpapong, F.J. Lukens et al. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Dig. Liver Dis. 50(11), 1166\u20131175 (2018). \nhttps:\/\/doi.org\/10.1016\/j.dld.2018.09.004\n\n.","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"2070_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jacc.2013.10.063","volume":"63","author":"SH Wan","year":"2014","unstructured":"S.H. Wan, M.W. Vogel, H.H. Chen, Pre-clinical diastolic dysfunction. J. Am. Coll. Cardiol. 63(5), 407\u2013416 (2014). \nhttps:\/\/doi.org\/10.1016\/j.jacc.2013.10.063\n\n.","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"2070_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5152\/akd.2014.5212","volume":"15","author":"AO Baktir","year":"2015","unstructured":"A.O. Baktir, B. Sarli, R.E. Altekin, A. Karaman, H. Arinc, H. Saglam et al. Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography. Anatol. J. Cardiol. 15(2), 137\u2013142 (2015). \nhttps:\/\/doi.org\/10.5152\/akd.2014.5212\n\n.","journal-title":"Anatol. J. Cardiol."},{"issue":"3","key":"2070_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5830\/CVJA-2014-068","volume":"26","author":"A Bekler","year":"2015","unstructured":"A. Bekler, E. Gazi, G. Erbag, E. Binnetoglu, A. Barutcu, H. Sen et al. Right ventricular function and its relationship with grade of hepatosteatosis in non-alcoholic fatty liver disease. Cardiovasc J. Afr. 26(3), 109\u2013113 (2015). \nhttps:\/\/doi.org\/10.5830\/CVJA-2014-068\n\n.","journal-title":"Cardiovasc J. Afr."},{"issue":"2","key":"2070_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2337\/dc11-1820","volume":"35","author":"S Bonapace","year":"2012","unstructured":"S. Bonapace, G. Perseghin, G. Molon, G. Canali, L. Bertolini, G. Zoppini et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care. 35(2), 389\u2013395 (2012). \nhttps:\/\/doi.org\/10.2337\/dc11-1820\n\n.","journal-title":"Diabetes Care."},{"key":"2070_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.03.027","volume":"272","author":"GE Chung","year":"2018","unstructured":"G.E. Chung, J.H. Lee, H. Lee, M.K. Kim, J.Y. Yim, S.Y. Choi et al. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction. Atherosclerosis 272, 137\u2013144 (2018). \nhttps:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.03.027\n\n.","journal-title":"Atherosclerosis"},{"issue":"9","key":"2070_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","volume":"19","author":"F Fallo","year":"2009","unstructured":"F. Fallo, A. Dalla Pozza, N. Sonino, M. Lupia, F. Tona, G. Federspil et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr. Metab. Cardiovasc. Dis. 19(9), 646\u2013653 (2009). \nhttps:\/\/doi.org\/10.1016\/j.numecd.2008.12.007\n\n.","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"5","key":"2070_CR12","first-page":"457","volume":"17","author":"H Fotbolcu","year":"2010","unstructured":"H. Fotbolcu, T. Yakar, D. Duman, T. Karaahmet, K. Tigen, C. Cevik et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol. J. 17(5), 457\u2013463 (2010). Epub 2010\/09\/25.","journal-title":"Cardiol. J."},{"issue":"10","key":"2070_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","volume":"40","author":"S Goland","year":"2006","unstructured":"S. Goland, S. Shimoni, T. Zornitzki, H. Knobler, O. Azoulai, G. Lutaty et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J. Clin. Gastroenterol. 40(10), 949\u2013955 (2006). \nhttps:\/\/doi.org\/10.1097\/01.mcg.0000225668.53673.e6\n\n.","journal-title":"J. Clin. Gastroenterol."},{"issue":"6","key":"2070_CR14","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/hepr.12770","volume":"47","author":"JY Jung","year":"2017","unstructured":"J.Y. Jung, S.K. Park, J.H. Ryoo, C.M. Oh, J.G. Kang, J.H. Lee et al. Effect of non-alcoholic fatty liver disease on left ventricular diastolic function and geometry in the Korean general population. Hepatol. Res. 47(6), 522\u2013532 (2017). \nhttps:\/\/doi.org\/10.1111\/hepr.12770\n\n.","journal-title":"Hepatol. Res."},{"issue":"12","key":"2070_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/heartjnl-2013-305099","volume":"100","author":"NH Kim","year":"2014","unstructured":"N.H. Kim, J. Park, S.H. Kim, Y.H. Kim, D.H. Kim, G.Y. Cho et al. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart 100(12), 938\u2013943 (2014). \nhttps:\/\/doi.org\/10.1136\/heartjnl-2013-305099\n\n.","journal-title":"Heart"},{"issue":"8","key":"2070_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135329","volume":"10","author":"A Mantovani","year":"2015","unstructured":"A. Mantovani, M. Pernigo, C. Bergamini, S. Bonapace, P. Lipari, I. Pichiri et al. Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes. PLoS ONE 10(8), e0135329 (2015). \nhttps:\/\/doi.org\/10.1371\/journal.pone.0135329\n\n.","journal-title":"PLoS ONE"},{"issue":"2","key":"2070_CR17","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.19082\/1984","volume":"8","author":"A Metwaly","year":"2016","unstructured":"A. Metwaly, A.A. Khalik, F.M. Nasr, A.I. Sabry, M.F. Gouda, M. Hassan, Brain natriuretic peptide in liver cirrhosis and fatty liver: correlation with cardiac performance. Electron Physician 8(2), 1984\u20131993 (2016). \nhttps:\/\/doi.org\/10.19082\/1984\n\n.","journal-title":"Electron Physician"},{"key":"2070_CR18","doi-asserted-by":"publisher","first-page":"363546","DOI":"10.5402\/2011\/363546","volume":"2011","author":"A Niaz","year":"2011","unstructured":"A. Niaz, Z. Ali, S. Nayyar, N. Fatima, Prevalence of NAFLD in healthy and young male individuals. ISRN Gastroenterol. 2011, 363546 (2011). \nhttps:\/\/doi.org\/10.5402\/2011\/363546\n\n.","journal-title":"ISRN Gastroenterol."},{"issue":"8","key":"2070_CR19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/oby.21879","volume":"25","author":"TG Simon","year":"2017","unstructured":"T.G. Simon, D.G. Bamira, R.T. Chung, R.B. Weiner, K.E. Corey, Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction. Obesity 25(8), 1313\u20131316 (2017). \nhttps:\/\/doi.org\/10.1002\/oby.21879\n\n.","journal-title":"Obesity"},{"issue":"5","key":"2070_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/1755-5922.12145","volume":"33","author":"M Sunbul","year":"2015","unstructured":"M. Sunbul, T. Kivrak, E. Durmus, H. Akin, Y. Aydin, R. Ergelen et al. Nonalcoholic steatohepatitis score is an independent predictor of right ventricular dysfunction in patients with nonalcoholic fatty liver disease. Cardiovasc Ther. 33(5), 294\u2013299 (2015). \nhttps:\/\/doi.org\/10.1111\/1755-5922.12145\n\n.","journal-title":"Cardiovasc Ther."},{"key":"2070_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijcard.2016.06.180","volume":"221","author":"FM Trovato","year":"2016","unstructured":"F.M. Trovato, G.F. Martines, D. Catalano, G. Musumeci, C. Pirri, G.M. Trovato, Echocardiography and NAFLD (non-alcoholic fatty liver disease). Int J. Cardiol. 221, 275\u2013279 (2016). \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2016.06.180\n\n.","journal-title":"Int J. Cardiol."},{"issue":"3","key":"2070_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/hep.27869","volume":"62","author":"LB VanWagner","year":"2015","unstructured":"L.B. VanWagner, J.E. Wilcox, L.A. Colangelo, D.M. Lloyd-Jones, J.J. Carr, J.A. Lima et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 62(3), 773\u2013783 (2015). \nhttps:\/\/doi.org\/10.1002\/hep.27869\n\n.","journal-title":"Hepatology"},{"key":"2070_CR23","unstructured":"G. Wells, B. Shea, D. O\u2019Connell, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses; 2013. \nhttp:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n\n. Accessed 2 Nov 2015."},{"issue":"7414","key":"2070_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"J.P. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman, Measuring inconsistency in meta-analyses. BMJ 327(7414), 557\u2013560 (2003). \nhttps:\/\/doi.org\/10.1136\/bmj.327.7414.557\n\n.","journal-title":"BMJ"},{"key":"2070_CR25","doi-asserted-by":"publisher","first-page":"213737","DOI":"10.1155\/2015\/213737","volume":"2015","author":"E Bonci","year":"2015","unstructured":"E. Bonci, C. Chiesa, P. Versacci, C. Anania, L. Silvestri, L. Pacifico, Association of nonalcoholic fatty liver disease with subclinical cardiovascular changes: a systematic review and meta-analysis. Biomed. Res Int. 2015, 213737 (2015). \nhttps:\/\/doi.org\/10.1155\/2015\/213737\n\n.","journal-title":"Biomed. Res Int."},{"issue":"7","key":"2070_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","volume":"15","author":"QM Anstee","year":"2018","unstructured":"Q.M. Anstee, A. Mantovani, H. Tilg, G. Targher, Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 15(7), 425\u2013439 (2018). \nhttps:\/\/doi.org\/10.1038\/s41575-018-0010-0\n\n.","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"2070_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/hep.22105","volume":"47","author":"E Bugianesi","year":"2008","unstructured":"E. Bugianesi, Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: another piece of the puzzle. Hepatology 47(1), 2\u20134 (2008). \nhttps:\/\/doi.org\/10.1002\/hep.22105\n\n.","journal-title":"Hepatology"},{"issue":"10","key":"2070_CR28","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/eurheartj\/ehr453","volume":"33","author":"LS Bhatia","year":"2012","unstructured":"L.S. Bhatia, N.P. Curzen, P.C. Calder, C.D. Byrne, Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur. Heart J. 33(10), 1190\u20131200 (2012). \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehr453\n\n.","journal-title":"Eur. Heart J."},{"issue":"9","key":"2070_CR29","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1161\/ATVBAHA.111.241984","volume":"32","author":"ED Abel","year":"2012","unstructured":"E.D. Abel, K.M. O\u2019Shea, R. Ramasamy, Insulin resistance: metabolic mechanisms and consequences in the heart. Arterioscler. Thromb. Vasc. Biol. 32(9), 2068\u20132076 (2012). \nhttps:\/\/doi.org\/10.1161\/ATVBAHA.111.241984\n\n.","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-02070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-02070-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-02070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:44:17Z","timestamp":1599003857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-02070-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-02070-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}